1. Home
  2. MRVI vs RXT Comparison

MRVI vs RXT Comparison

Compare MRVI & RXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

N/A

Current Price

$7.29

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Logo Rackspace Technology Inc.

RXT

Rackspace Technology Inc.

N/A

Current Price

$3.91

Market Cap

1.2B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
MRVI
RXT
Founded
2014
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
MRVI
RXT
Price
$7.29
$3.91
Analyst Decision
Buy
Hold
Analyst Count
4
6
Target Price
$4.13
$1.71
AVG Volume (30 Days)
4.6M
6.1M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
14.29
75.13
EPS
N/A
N/A
Revenue
$185,743,000.00
$2,685,700,000.00
Revenue This Year
$12.54
N/A
Revenue Next Year
$7.87
$1.35
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.55
$0.39
52 Week High
$9.42
$8.60

Technical Indicators

Market Signals
Indicator
MRVI
RXT
Relative Strength Index (RSI) 47.43 48.92
Support Level $5.54 $2.88
Resistance Level $7.44 $3.56
Average True Range (ATR) 0.33 0.24
MACD -0.14 0.09
Stochastic Oscillator 17.23 79.75

Price Performance

Historical Comparison
MRVI
RXT

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

About RXT Rackspace Technology Inc.

Rackspace Technology Inc is an end-to-end, hybrid, multi-cloud technology services company. It designs, builds, and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services, Data, Colocation, Cloud, Managed Hosting, Professional Services, and Security and Compliance. It has two reportable segments: Private Cloud and Public Cloud. Maximum revenue is generated from the Public Cloud segment, which offers cloud solutions through managed services, elastic engineering, and professional services offerings for customer environments hosted on the AWS, Microsoft Azure, and Google Cloud public cloud platforms. Geographically, the company derives its key revenue from the U.S.

Share on Social Networks: